Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-04

Clinical Trial Update: Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity [NA]

View source ↗

Summary

This completed trial compared myo-inositol to metformin for treating obesity in people with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myo-inositol (myo-inositol)
  • metformin (metformin)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Polycystic Ovarian Syndrome | NA | Status: COMPLETED